Replies to post #994 on Oxigene Inc fka OXGN

[Ask kicker]

$OXGN I'm thinking about the same, ~$6. IMO


OXiGENE Gets U.S. Patent for Myeloid Neoplasms Treatment - Jumping 7% in After-Hours
BY Midnight Trader
— 4:10 PM ET 05/26/2015

04:10 PM EDT, 05/26/2015 (MT Newswires) -- OXiGENE ( OXGN) , a biopharmaceutical company developing novel therapies for the treatment of cancer, today said the U.S. Patent and Trademark Office has granted it a patent (U.S. Patent No. 9,040,500) related to the use of OXi4503 for the treatment of myeloid neoplasms, including acute myeloid leukemia (AML).

Price: 1.49, Change: +0.10, Percent Change: +7.1